Curanex Pharmaceuticals Inc.

Curanex Pharmaceuticals Inc. is a developmental-stage pharmaceutical company focused on discovering, developing, and commercializing botanical drugs for inflammatory diseases. The company’s lead program centers on Phyto-N, a botanical drug candidate being studied across multiple therapeutic areas, including ulcerative colitis, atopic dermatitis, diabetes, gout, nonalcoholic fatty liver disease, and certain viral and immune-related conditions. Curanex Pharmaceuticals Inc. operates in the healthcare sector and participates in the biotechnology and pharmaceuticals market through research-driven product development aimed at unmet medical needs. Headquartered in Jericho, New York, the company is positioned as a specialty developer of plant-based therapeutics with a pipeline strategy centered on inflammation-related indications.

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Jun Liu

Employees

6

Headquarters

Jericho, NY, United States

Website

www.curanexpharma.com